PharmaLex expands pricing & reimbursement and health economics platform with EBMA Consulting merger
Merger with PharSolution strengthens reach across Europe with end-to-end compliance services to support the development process
Frankfurt, Germany – 30 November 2021: Pharmalex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced a merger with pharmaceutical and biotechnology consulting company PharSolution.
Founded in 1999, PharSolution has deep expertise across regulatory affairs, market access, medical writing, pharmacovigilance, GxP and strategic advice, and strong partnerships with institutions and health authorities in Portugal and at the European Medicines Agency and European Commission. PharSolution has a roster of more than 120 customers, including global players in the pharmaceutical sector, most of whom have used the company’s services on multiple occasions.
“The merger with PharmaLex provides our clients with broader reach across all our key value areas” said Alex Ramos, CEO, PharSolution. “With a long-term commitment to customer satisfaction, we look forward to the opportunity to help more lifescience companies in the pursuit of excellence and to being able to offer our customers access to more markets and a broader base of compliance experts.”
“We are delighted to welcome the PharSolution team to the PharmaLex Group, and at the prospect of further expanding our technology-enabled service solutions portfolio with the integration of PharSolution’s three technology platforms that further enhance our existing pharmacovigilance databases globally,” said PharmaLex CEO Dr. Thomas Dobmeyer. “The merger furthermore enables us to deliver local affiliate support in Portugal for all our solutions across our service centers – regulatory, pharmacovigilance, risk management, quality and manufacturing, strategic advice and scientific affairs – as we continue to build on our global approach while providing local support.”
Suspendisse facilisis neque a sem faucibus, nec porttitor dolor vulputate. Maecenas aliquam justo enim, id dapibus eros pretium a. Nulla sit amet lectus at leo luctus varius non et urna. In quis felis tristique, posuere lectus vitae, ultrices neque. Aliquam sit amet turpis ut dui feugiat dignissim. Donec at nisi tellus. Nulla auctor commodo porttitor.
-Ends-
About PharmaLex <Confidence beyond compliance>
PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.
The PharmaLex Group now has over 1,700 employees, with 45 offices in 24 countries and more than 1,000 satisfied clients worldwide.
For further information, please contact:
Ms. Elizabeth Hunt; PharmaLex GmbH; Manager External Communications
elizabeth.hunt@pharmalex.com
+00 353 86 811 2319
Harrlachweg 6; 68163 Mannheim; Germany
Related posts
